abstract |
The present invention relates to a novel non-secosteroidal, hydroxy-substituted, diaryl compound bonded to a carbon atom having a vitamin D receptor (VDR) -modulating activity that is less capable of hypercalcemia than 1α, 25-dihydroxyvitamin D3. Related. These compounds are useful for the treatment of bone disease and psoriasis. |